Meghmani Posts Rs 2B FY25 Revenue, Returns to Profit

14 May 2025 CW Team

For the fourth quarter (Q4 FY25), the company posted revenue of Rs 5.02 billion—up 26 per cent year-on-year—driven by an improved product mix across both segments. EBITDA surged more than sixfold to Rs 646 million, from Rs 101 million in Q4 FY24.

The crop protection segment continued to be the company’s main revenue driver, contributing 72 per cent of the total in FY25. It recorded revenue of Rs 1.45 billion and EBITDA of Rs 1.77 billion, up 34 per cent and 301 per cent year-on-year, respectively, with production volume rising 14 per cent to 41,892 metric tonnes at 76 per cent capacity utilisation.

The pigments segment generated revenue of Rs 553.3 million, up 20 per cent year-on-year, and returned to profitability with an EBITDA of Rs 269 million, compared to a loss in the previous year. Production rose 11 per cent to 15,237 metric tonnes, with capacity utilisation at 46 per cent.

Chairman and Managing Director Ankit Patel noted that both business segments saw healthy volume growth from Q2 onwards, bolstered by the company’s focus on product mix optimisation. The firm’s crop nutrition division achieved self-sufficiency in FY25, and plans are under way to launch 2–3 new products in FY26.

In the titanium dioxide (TiO₂) space, Meghmani is facing utilisation pressure due to aggressive dumping by Chinese firms. However, the Directorate General of Trade Remedies has recommended anti-dumping duties of USD 460–681 per metric tonne on Chinese TiO₂ imports, which is expected to stabilise the domestic market. Meghmani is also targeting exports to improve realisations.

The company aims to continue strengthening its product pipeline, expanding market share, and enhancing operational efficiency in the year ahead.

Image source: agrospectrumindia

Meghmani Organics Limited (BSE: 543331, NSE: MOL), a fully integrated and diversified chemical company, reported a strong recovery for the financial year ended 31 March 2025 (FY25), with a 30 per cent year-on-year increase in revenue from operations to Rs 2 billion and a profit after tax of Rs 664 million, compared to a loss of Rs 566 million in the previous year.For the fourth quarter (Q4 FY25), the company posted revenue of Rs 5.02 billion—up 26 per cent year-on-year—driven by an improved product mix across both segments. EBITDA surged more than sixfold to Rs 646 million, from Rs 101 million in Q4 FY24.The crop protection segment continued to be the company’s main revenue driver, contributing 72 per cent of the total in FY25. It recorded revenue of Rs 1.45 billion and EBITDA of Rs 1.77 billion, up 34 per cent and 301 per cent year-on-year, respectively, with production volume rising 14 per cent to 41,892 metric tonnes at 76 per cent capacity utilisation.The pigments segment generated revenue of Rs 553.3 million, up 20 per cent year-on-year, and returned to profitability with an EBITDA of Rs 269 million, compared to a loss in the previous year. Production rose 11 per cent to 15,237 metric tonnes, with capacity utilisation at 46 per cent.Chairman and Managing Director Ankit Patel noted that both business segments saw healthy volume growth from Q2 onwards, bolstered by the company’s focus on product mix optimisation. The firm’s crop nutrition division achieved self-sufficiency in FY25, and plans are under way to launch 2–3 new products in FY26.In the titanium dioxide (TiO₂) space, Meghmani is facing utilisation pressure due to aggressive dumping by Chinese firms. However, the Directorate General of Trade Remedies has recommended anti-dumping duties of USD 460–681 per metric tonne on Chinese TiO₂ imports, which is expected to stabilise the domestic market. Meghmani is also targeting exports to improve realisations.The company aims to continue strengthening its product pipeline, expanding market share, and enhancing operational efficiency in the year ahead.Image source: agrospectrumindia

Infrastructure Urban

10 Mar 2026

ABB to Invest Rs 6.25 Billion to Expand India Manufacturing

ABB recently announced plans to invest approximately Rs 6.25 billion ($75 million) in India during 2026 to expand its manufacturing footprint and research and development capabilities. The investment follows more than $35 million spent in 2025 and reflects the company’s continued focus on strengthening its ‘local-for-local’ strategy in the country.The investment will support ABB’s Electrification, Motion and Automation businesses and expand manufacturing capacity for infrastructure sectors such as renewable energy, metro rail, data centres and industrial applications. Approximately 300..

Equipment

10 Mar 2026

Six WOLFF Cranes Handle 60,000 m³ Concrete for German Hospital

Six WOLFF tower cranes are playing a key role in constructing a new hospital complex in Memmingen, Germany, supporting large-scale material handling for the project. The facility is being built on a 7.7-hectare site and will feature six floors, around 480 beds and a gross floor area exceeding 75,000 sq m.Building shell works began recently in February 2025. One WOLFF 6531.12 Cross crane supported early site preparation before being dismantled in autumn 2025, while five remaining cranes continue operations. Over an average deployment period of 16 months, the cranes are expected to move approxim..

Equipment

10 Mar 2026

REC Funds Rs 115.6 Million CSR Support for Bihar Eye Hospital

REC recently committed Rs 115.6 million under its Corporate Social Responsibility (CSR) programme for the procurement of clinical and non-clinical equipment at Sankara Eye Hospital in Saharsa, Bihar. The initiative aims to strengthen healthcare infrastructure and improve access to specialised eye care services in the region.A Memorandum of Agreement (MoA) was recently signed between Pradeep Fellows, Executive Director (CSR), REC Limited, and Wg Cdr V. Shankar (Retd), Trustee and Executive Director of Sankara Eye Hospital, at the REC office in the SCOPE Complex, New Delhi.The support is expecte..